Andrew Godkin

8PUBLICATIONS
30CO-AUTHORS
Innate immunityMolecular targetsTumour immunologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Sep 21, 2022
Magnitude of venous or capillary blood-derived SARS-CoV-2-specific T cell response determines COVID-19 immunity.

Martin J Scurr, George Lippiatt, Lorenzo Capitani

|Mar 10, 2022
Seven mysteries of LAG-3: a multi-faceted immune receptor of increasing complexity.

Stephanie E A Burnell, Lorenzo Capitani, Bruce J MacLachlan

|Nov 14, 2021
Whole blood-based measurement of SARS-CoV-2-specific T cells reveals asymptomatic infection and vaccine immunogenicity in healthy subjects and patients with solid-organ cancers.

Martin J Scurr, Wioleta M Zelek, George Lippiatt

|Oct 07, 2020
Immune Remodeling of the Extracellular Matrix Drives Loss of Cancer Stem Cells and Tumor Rejection.

Ana Pires, Alexander Greenshields-Watson, Emma Jones

|Mar 04, 2020
Cancer Antigen Discovery Is Enabled by RNA Sequencing of Highly Purified Malignant and Nonmalignant Cells.

Martin J Scurr, Alex Greenshields-Watson, Emma Campbell

|Oct 18, 2019
Human leukocyte antigen (HLA) class II peptide flanking residues tune the immunogenicity of a human tumor-derived epitope.

Bruce J MacLachlan, Garry Dolton, Athanasios Papakyriakou

Pageof 2

Frequent Collaborators

5 joint publications

Martin J Scurr

5 joint publications

Awen M Gallimore

3 joint publications

Bruce J MacLachlan

2 joint publications

Alexander Greenshields-Watson